Asthma  >>  Riarify (beclometasone/formoterol/glycopyrrolate)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Riarify (beclometasone/formoterol/glycopyrrolate) / Chiesi
NCT05728749: A Multicentre, Prospective, Non-interventional Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extra-fine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Outcomes

Recruiting
N/A
300
Europe
Non-interventional
Chiesi SAS, Gesellschaft für Therapieforschung mbH
ASTHMA
03/24
03/25
TriMaximize, NCT04902573: A Trial Monitoring Therapy Pathways of Asthma Patients Treated With an Extrafine ICS/LABA/LAMA Single-inhaler Triple Therapy in a Real-world Setting and Characterizing the Effects on Health-related Out-comes

Active, not recruiting
N/A
200
Europe
Non-interventional
Chiesi UK, Gesellschaft für Therapieforschung mbH
Asthma
06/24
06/24
TRIMAXIMIZE, NCT06100042: Observational Study on Therapy Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy in a Real-world Setting

Recruiting
N/A
200
Europe
BDP/FF/G, Trimbow
Chiesi Italia, Gesellschaft für Therapieforschung mbH
Asthma
10/25
10/25

Download Options